Home
/
Sensus Healthcare, Inc.
/
Financials
/
Quarterly
Sensus Healthcare, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Sensus Healthcare, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$6.88M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$7.32M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$8.34M
May 15, 2025
Q3
2025
Sep 30, 2024
$8.84M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$9.24M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$10.66M
May 15, 2025
Q3
2024
Sep 30, 2023
$3.90M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$4.53M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$3.41M
May 10, 2024
Q3
2023
Sep 30, 2022
$9.01M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$12.08M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$10.34M
May 12, 2023
Q3
2022
Sep 30, 2021
$5.53M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$5.42M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$3.07M
May 12, 2022
Q3
2021
Sep 30, 2020
$1.62M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$1.18M
Aug 13, 2021
Q1
2021
Mar 31, 2020
$1.68M
May 14, 2021
Q3
2020
Sep 30, 2019
$5.84M
Nov 10, 2020
Q2
2020
Jun 30, 2019
$7.48M
Aug 10, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$6.88M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$7.32M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$8.34M
May 15, 2025
Q3
2025
Sep 30, 2024
$8.84M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$9.24M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$10.66M
May 15, 2025
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$4.80M
Nov 6, 2017
Q2
2017
Jun 30, 2017
$4.97M
Aug 4, 2017
Q1
2017
Mar 31, 2017
$4.35M
May 9, 2017
Q3
2017
Sep 30, 2016
$3.33M
Nov 6, 2017
Q2
2017
Jun 30, 2016
$3.57M
Aug 4, 2017
Q1
2017
Mar 31, 2016
$3.04M
May 9, 2017
Q3
2016
Sep 30, 2015
$2.11M
Nov 7, 2016
Q2
2016
Jun 30, 2015
$2.40M
Aug 15, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($943.0K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($1.04M)
Aug 12, 2025
Q3
2025
Jun 30, 2025
($1.04M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($2.57M)
May 15, 2025
Q3
2025
Mar 31, 2025
($2.57M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($2.57M)
Aug 12, 2025
Q3
2025
Sep 30, 2024
$1.22M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$1.61M
Aug 12, 2025
Q3
2025
Jun 30, 2024
$1.61M
Nov 12, 2025
Q2
2025
Mar 31, 2024
$2.27M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$2.27M
May 15, 2025
Q3
2025
Mar 31, 2024
$2.27M
Nov 12, 2025
Q3
2024
Sep 30, 2023
($1.45M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($380.0K)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($380.0K)
Nov 14, 2024
Q3
2024
Mar 31, 2023
($1.89M)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($1.89M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($1.89M)
May 10, 2024
Q3
2023
Sep 30, 2022
$1.83M
Nov 13, 2023
Q3
2023
Jun 30, 2022
$3.52M
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.57M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($1.94M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($2.65M)
May 15, 2025
Q3
2025
Sep 30, 2024
$1.50M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$1.98M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$2.89M
May 15, 2025
Q3
2024
Sep 30, 2023
($1.90M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.13M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($2.94M)
May 10, 2024
Q3
2023
Sep 30, 2022
$2.16M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$4.57M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$3.93M
May 12, 2023
Q3
2022
Sep 30, 2021
$195.0K
Nov 10, 2022
Q2
2022
Jun 30, 2021
($279.0K)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($1.12M)
May 12, 2022
Q3
2021
Sep 30, 2020
($2.28M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($2.57M)
Aug 13, 2021
Q1
2021
Mar 31, 2020
($3.64M)
May 14, 2021
Q3
2020
Sep 30, 2019
($805.1K)
Nov 10, 2020
Q2
2020
Jun 30, 2019
$45.5K
Aug 10, 2020